- Record: found
- Abstract: found
- Article: not found
Clinical outcomes of patients treated with Nobori biolimus-eluting stent: Meta-analysis of randomized trials.
Salvatore Cassese
1 ,
Massimiliano Fusaro
2 ,
Robert A Byrne
2 ,
Tomohisa Tada
2 ,
Petra Hoppmann
3 ,
Michael Joner
2 ,
Karl-Ludwig Laugwitz
3 ,
Heribert Schunkert
2 ,
Adnan Kastrati
2
Aug 20 2014
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The Nobori is a new-generation, biodegradable-polymer coated, biolimus-eluting stent (BES) that has recently been investigated in several randomized trials with inconsistent results. The aim of this study was to assess the efficacy and safety of Nobori BES versus other drug-eluting stents (DES) in patients treated with percutaneous coronary intervention (PCI).